Onset of systemic lupus erythematosus during pregnancy

Journal of the Chinese Medical Association

Volumn 69, Issue 3, 2006, Pages 130-133

  Yang, Ming Jie ^a   Cheng, Ming Huei ^a   Lin, Hsiao Yi ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Immunosuppressive agents; Pregnancy; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; COLCHICINE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC TEST; FEMALE; HUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 33645350137     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70191-1     Document Type: Article

References (16)

1. Branch DW, Porter TF. Autoimmune disease. In: James DK, Steer PJ, Weiner CP, Gonik B, eds. High Risk Pregnancy. Management Options, 2nd ed. London: WB Saunders, 1999: 853-84.
2. Borden MB, Parke AL. Antimalarial drugs in systemic lupus erythematosus. Use in pregnancy. Drug Safety 2001;24:1055-63.
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
4. Gallery ED, Raftos J, Gyory AZ, Wells JV. A prospective study of serum complement (C3 and C4) levels during normal human pregnancy: effect of the development of pregnancy-associated hypertension. Aust NZ J Med 1981;11:243-5.
5. Ter Borg EJ, Hurst G, Hummel EJ, Limburg PC, Kallenberg CGM. Measurements of increases in anti-double stranded DNA antibody levels as predictor of disease exacerbation in SLE: a long term, prospective study. Arthritis Rheum 1990; 33:634-43.
6. Tomer Y, Viegas OAC, Swissa M, Koh SCL, Shoenfeld Y. Levels of lupus autoantibodies in pregnant SLE patients: correlations with disease activity and pregnancy outcome. Clin Exp Rheum 1996;14:275-80.
7. Köseoglu HK, Yücel AE, Künefeci G, Ösdemir FN, Duran H. Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus 2001;10:818-20.
8. Levy RA, Vilela VS, Cataldo MJ, Ramos RC, Duarte JL, Tura BR, Albuquerque EM, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double blind and placebo-controlled study. Lupus 2001;10:410-4.
9. The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991;324:150-4.
10. Abu-Shakra M, Shoenfeld Y. Azathioprine therapy for patients with systemic lupus erythematosus. Lupus 2001;10:152-3.
11. Scott JR. Fetal growth retardation associated with maternal administration of immuno-suppressive drugs. Am J Obstet Gynecol 1977;128:668-76.
12. Cote CJ, Meuwissen HJ, Pickering RJ. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 1974;85:324-8.
13. Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre P, Bach JF. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 1982;142:771-6.
14. Imbasciati E, Surian M, Bottino S, Cosci P, Colussi G, Ambroso GC, Massa E, et al. Lupus nephropathy and pregnancy. Nephron 1984;36:46-51.
15. Varner MW, Meehan RT, Syrop CH, Strottman MP, Goplerud CP. Pregnancy in patients with systemic lupus erythematosus. Am J Obstet Gynecol 1983;145:1025-40.
16. Lockshin MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989;32:665-70.